These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36444426)

  • 1. [Interpretation on the 2021 European League Against Rheumatism and American College of Rheumatology points to consider for diagnosis and management of autoinflammatory type Ⅰ interferonopathies].
    Zhou Y; Song HM
    Zhonghua Er Ke Za Zhi; 2022 Dec; 60(12):1258-1261. PubMed ID: 36444426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correspondence on 'The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease'.
    Peters RJR; Martin H; Virdee A; Fryer E; Bungay H; Rodriguez-Justo M; Chouhan M; Barnes E; Webster G; Culver EL
    Ann Rheum Dis; 2023 Sep; 82(9):e210. PubMed ID: 33148699
    [No Abstract]   [Full Text] [Related]  

  • 3. Correspondence on 'The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease' by Wallace
    Yardımcı GK; Yıldırım BES; Farisoğulları B; Kilic L; Karadag O
    Ann Rheum Dis; 2023 Dec; 82(12):e230. PubMed ID: 35817470
    [No Abstract]   [Full Text] [Related]  

  • 4. European League against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus: the laboratory immunologist's point of view.
    Infantino M; Manfredi M; Bizzaro N;
    Ann Rheum Dis; 2021 Dec; 80(12):e188. PubMed ID: 31757781
    [No Abstract]   [Full Text] [Related]  

  • 5. The 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology points to consider for diagnosis and management of autoinflammatory type I interferonopathies: CANDLE/PRAAS, SAVI and AGS.
    Cetin Gedik K; Lamot L; Romano M; Demirkaya E; Piskin D; Torreggiani S; Adang LA; Armangue T; Barchus K; Cordova DR; Crow YJ; Dale RC; Durrant KL; Eleftheriou D; Fazzi EM; Gattorno M; Gavazzi F; Hanson EP; Lee-Kirsch MA; Montealegre Sanchez GA; Neven B; Orcesi S; Ozen S; Poli MC; Schumacher E; Tonduti D; Uss K; Aletaha D; Feldman BM; Vanderver A; Brogan PA; Goldbach-Mansky R
    Ann Rheum Dis; 2022 May; 81(5):601-613. PubMed ID: 35086813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology Points to Consider for Diagnosis and Management of Autoinflammatory Type I Interferonopathies: CANDLE/PRAAS, SAVI, and AGS.
    Cetin Gedik K; Lamot L; Romano M; Demirkaya E; Piskin D; Torreggiani S; Adang LA; Armangue T; Barchus K; Cordova DR; Crow YJ; Dale RC; Durrant KL; Eleftheriou D; Fazzi EM; Gattorno M; Gavazzi F; Hanson EP; Lee-Kirsch MA; Montealegre Sanchez GA; Neven B; Orcesi S; Ozen S; Poli MC; Schumacher E; Tonduti D; Uss K; Aletaha D; Feldman BM; Vanderver A; Brogan PA; Goldbach-Mansky R
    Arthritis Rheumatol; 2022 May; 74(5):735-751. PubMed ID: 35315249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do 2019 European League against rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus also indicate the disease activity?
    Teng J; Zhou Z; Wang F; Sun Y; Liu HL; Cheng X; Su Y; Shi H; Yang C; Ye J
    Ann Rheum Dis; 2022 Feb; 81(2):e22. PubMed ID: 32122908
    [No Abstract]   [Full Text] [Related]  

  • 8. Response to: 'Do 2019 European League against rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus also indicate the disease activity?' by Teng
    Aringer M; Costenbader K; Dörner T; Johnson SR
    Ann Rheum Dis; 2022 Feb; 81(2):e23. PubMed ID: 32122907
    [No Abstract]   [Full Text] [Related]  

  • 9. American College of Rheumatology and the European League Against Rheumatism classification criteria for IgG4-related disease: an update for radiologists.
    Ren H; Mori N; Sato S; Mugikura S; Masamune A; Takase K
    Jpn J Radiol; 2022 Sep; 40(9):876-893. PubMed ID: 35474439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homologies and heterogeneity between Rheumatology Congresses: Mexican, American College of Rheumatology and European League Against Rheumatism.
    Cuevas-Orta E; Pedro-Martínez ÁJ; Ramírez-Rodríguez C; Abud-Mendoza C
    Reumatol Clin (Engl Ed); 2020; 16(2 Pt 1):87-91. PubMed ID: 29891264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The balance between clinical convenience and the new concepts of the 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies.
    Kim HS
    Korean J Intern Med; 2021 Mar; 36(2):288-291. PubMed ID: 33725435
    [No Abstract]   [Full Text] [Related]  

  • 12. Response to: 'Performance of the 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies in clinical practice' by Hočevar
    Lundberg IE; Bottai M; Tjärnlund A
    Ann Rheum Dis; 2018 Dec; 77(12):e91. PubMed ID: 29317406
    [No Abstract]   [Full Text] [Related]  

  • 13. Response to: 'European League against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus: the laboratory immunologist's point of view' by Infantino
    Aringer M; Costenbader KH; Dörner T; Johnson SR
    Ann Rheum Dis; 2021 Dec; 80(12):e189. PubMed ID: 31831507
    [No Abstract]   [Full Text] [Related]  

  • 14. Exclusion of Cutaneous Lupus Erythematosus Subtypes From the 2019 European League Against Rheumatism/American College of Rheumatology Classifi cation Criteria for Systemic Lupus Erythematosus: Comment on the Article by Aringer et al.
    Zapata L; Chong BF
    Arthritis Rheumatol; 2020 Aug; 72(8):1403. PubMed ID: 32336046
    [No Abstract]   [Full Text] [Related]  

  • 15. Does Leukopenia Influence Performance of the New European League Against Rheumatism/American College of Rheumatology Classification Criteria in an African-Descendent Population With Childhood-Onset Systemic Lupus Erythematosus? Comment on the Article by Aringer et al.
    Fonseca AR; Rodrigues MCF; Sztajnbok F; Land MGP; de Oliveira SKF
    Arthritis Rheumatol; 2020 Apr; 72(4):694-695. PubMed ID: 31769215
    [No Abstract]   [Full Text] [Related]  

  • 16. American College of Rheumatology/European League Against Rheumatism Sjögren's Syndrome Classification Criteria May Not Be Adequate for Extraglandular Disease and Necessitate Defining "Seronegative Sjögren's Syndrome": Comment on the Article by Shiboski et al.
    Tezcan ME; Kucuk H; Goker B
    Arthritis Rheumatol; 2017 Jun; 69(6):1341-1342. PubMed ID: 28245349
    [No Abstract]   [Full Text] [Related]  

  • 17. Curious Case of a Retroperitoneal Mass With an Elevated Serum IgG3 Level-An Exception to the 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease: Comment on the Article by Wallace et al.
    Levine J; Luisiri P
    Arthritis Rheumatol; 2020 Nov; 72(11):1957-1958. PubMed ID: 32564475
    [No Abstract]   [Full Text] [Related]  

  • 18. Common Language Description of the Term Rheumatic and Musculoskeletal Diseases (RMDs) for Use in Communication With the Lay Public, Healthcare Providers, and Other Stakeholders Endorsed by the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR).
    van der Heijde D; Daikh DI; Betteridge N; Burmester GR; Hassett AL; Matteson EL; van Vollenhoven R; Lakhanpal S
    Arthritis Rheumatol; 2018 Jun; 70(6):826-831. PubMed ID: 29532625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common language description of the term rheumatic and musculoskeletal diseases (RMDs) for use in communication with the lay public, healthcare providers and other stakeholders endorsed by the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR).
    van der Heijde D; Daikh DI; Betteridge N; Burmester GR; Hassett AL; Matteson EL; van Vollenhoven R; Lakhanpal S
    Ann Rheum Dis; 2018 Jun; 77(6):829-832. PubMed ID: 29525777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rheumatology in Egypt: back to the future.
    Gheita TA; Eesa NN
    Rheumatol Int; 2019 Jan; 39(1):1-12. PubMed ID: 30406299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.